Harborfront Financial Group LLC

Position in MRK — Merck & Co., Inc.

CIK 2110061 LUDINGTON, MI

Position in MRK

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$80,184

New position

Shares Held

624

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.67%

of 13F equity value

Holder Rank

#3,611

of 3,769 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Harborfront Financial Group LLC holds $636,529 across 6 Drug Manufacturers - General names. MRK ranks #3 (12.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	294	$352,632
2	JNJ	Johnson & Johnson	514	$130,540
3	MRK	Merck & Co., Inc. This page	624	$80,184
4	ABBV	AbbVie Inc.	242	$60,896
5	PFE	Pfizer Inc	475	$11,438
6	OGN	Organon & Co.	62	$839

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$80,184	624	—	Shares	Sole	2026-08-07
No filing history on record for this holder in this stock.